Therapeutics, Inc. (NASDAQ:APGE), has sold 15,000 shares of the company's common stock, according to a recent SEC filing. The biotech company, currently valued at $2.37 billion, has received a ...

Officer of Apogee (NASDAQ:APOG) Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biopharmaceutical company with a market capitalization of $2.4 billion, recently sold shares of the company's common ...

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solu ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...